Shen AI Vitals is now ANVISA approved
Shen AI Vitals has officially received ANVISA approval, confirming its readiness for use in regulated digital health solutions across Brazil.
Shen AI Vitals receives ANVISA approval as a class II medical device in Brazil
Shen AI Vitals has officially received ANVISA approval. This marks a major milestone in our mission to deliver clinically trusted, contactless health insights across digital health, insurance, and telemedicine platforms.
ANVISA (Agência Nacional de Vigilância Sanitária) is Brazil’s National Health Surveillance Agency and one of the most respected regulatory bodies in Latin America. Its approval of Shen AI Vitals confirms that our technology meets the safety, performance, and regulatory requirements for use in Brazil’s healthcare ecosystem.
What ANVISA approval involves
Shen AI Vitals is registered with ANVISA under approval number 81464750186 under RDC 751/2022 as a class II medical device under rule 11 (software that monitors physiological functions) for mobile and web deployment.
All signal processing and metric extraction are performed locally on the user’s device, ensuring compliance with relevant privacy standards.
Enabling faster integration in regulated LATAM markets
With ANVISA approval in place, Shen.AI Vitals is now available for integration into regulated digital health solutions across Brazil. This enables developers, healthcare providers, and insurers to:
- Confidently integrate contactless, clinically validated health monitoring into their platforms
- Streamline compliance for solutions involving physiological measurements
- Accelerate development cycles and reduce regulatory complexity
- Offer real-time health insights to broader populations without requiring wearables or external hardware
This opens the door to new use cases in teleconsultation, chronic care, remote triage, and digital wellness, all powered by a face scan with a standard device camera.
What Shen.AI Vitals measures
Shen AI Vitals provides real-time estimates of heart rate and heart rate variability (HRV), blood pressure as well as respiratory rate with contactless, camera-based measurements. The health metrics are derived using remote photoplethysmography (rPPG) - with no need for wearables or external sensors.
See what’s possible with Shen AI Vitals
With ANVISA approval, Shen AI Vitals is now part of the regulated digital health landscape in Brazil. If you're exploring ways to bring real-time, camera-based health insights into your product -without adding hardware or complexity - we’d love to show you how it works.
Schedule a demo and see how it could fit into your roadmap.
More blog posts
Sagittis et eu at elementum, quis in. Proin praesent volutpat egestas sociis sit lorem nunc nunc sit.
What’s changing in women’s health - and what still isn’t
Despite growing investment in femtech, women’s health is still shaped by data gaps and system-level bias. This discussion explores how better data, thoughtful AI, and more intentional product design can move from tracking to real understanding.
The FDA's 2026 general wellness update and what it means for health monitoring
The FDA’s 2026 update expands what qualifies as general wellness, but applying it correctly is where most teams struggle. This webinar recap breaks down the key changes, common compliance pitfalls, and how product, marketing, and AI decisions shape regulatory risk in digital health.
Wellness or medical product? In 2026, it’s all in the framing
The FDA's 2026 General Wellness guidance update changes the conversation for digital health teams. Here's what it means - and why it matters right now.